Open AccessEfficacy and safety of terbinafine 500 mg once daily in patients with dermatophytosis
Author(s) -
P Ravindra Babu,
A. J. S. Pravin,
Gaurav Deshmukh,
Dhiraj Dhoot,
Aniket Samant,
Bhavesh Kotak
Publication year - 2017
Publication title -
indian journal of dermatology/indian journal of dermatology
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.395
H-Index - 36
eISSN - 1998-3611
pISSN - 0019-5154
DOI - 10.4103/ijd.ijd_191_17
Subject(s) - terbinafine , medicine , group b , adverse effect , potency , lesion , dermatology , group a , surgery , antifungal , biochemistry , chemistry , itraconazole , in vitro
Dermatophytosis are the most common fungal infections globally. Terbinafine is considered to have good potency against dermatophytes, but resistance to terbinafine is on the rise.